In last trading session, Vaxart, Inc. (NASDAQ:VXRT) saw 13,973,395 shares changing hands with its beta currently measuring -0.04. Company’s recent per share price level of $6.3 trading at -$0.6 or -8.7% at ring of the bell on the day assigns it a market valuation of $689.66 Million. That closing price of VXRT’s stock is at a discount of -177.62% from its 52-week high price of $17.49 and is indicating a premium of 95.71% from its 52-week low price of $0.27. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 11.82 Million shares which gives us an average trading volume of 21.92 Million if we extend that period to 3-months.

For Vaxart, Inc. (VXRT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. Splitting up the data highlights that, out of 3 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 3 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.09 in the current quarter.

Vaxart, Inc. (NASDAQ:VXRT) trade information

Wall Street analysts have assigned a consensus price target of $19.67 to the stock, which implies a rise of 212.22% to its current value. Analysts have been projecting $17 as a low price target for the stock while placing it at a high target of $22. It follows that stock’s current price would jump +249.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of 169.84% for stock’s current value.

Vaxart, Inc. (VXRT) estimates and forecasts

Statistics highlight that Vaxart, Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company added +216.58% of value to its shares in past 6 months, showing an annual growth rate of -59.3% while that of industry is 15.5. Apart from that, the company came raising its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to increase by 71.9% in the current quarter and calculating 30.8% increase in the next quarter. This year revenue growth is estimated to drop -24.9% from the last financial year’s standing.

3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $1.07 Million for the same. And 3 analysts are in estimates of company making revenue of $2.9 Million in the next quarter that will end in December 01, 2020. Company posted $440Million and $3.92 Million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 143.2% while estimating it to be -25.9% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 32% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 70.2% while estimates for its earnings growth in next 5 years are of 0%

Vaxart, Inc. (NASDAQ:VXRT)’s Major holders

Insiders are in possession of 1.21% of company’s total shares while institution are holding 36.23% percent of that, with stock having share float percentage of 36.68%. Investors also watch the number of corporate investors in a company very closely, which is 36 institutions for Vaxart, Inc. that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at VXRT for having 3.37 Million shares of worth $29.79 Million. And as of June 29, 2020, it was holding 3.08% of the company’s outstanding shares.

The second largest institutional holder is Citadel Advisors LLC, which was holding about 3.1 Million shares on June 29, 2020. The number of shares represents firm’s hold over 2.84% of outstanding shares, having a total worth of $27.41 Million.

On the other hand, iShares Russell 2000 ETF and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of August 30, 2020, the former fund manager was holding 952875 shares of worth $5.65 Million or 0.87% of the total outstanding shares. The later fund manager was in possession of 618.03 Thousand shares on June 29, 2020, making its stake of worth around $5.47 Million in the company or a holder of 0.57% of company’s stock.